Persistent urinary phosphate wasting in a patient with metastatic breast cancer: What's your diagnosis?
We report a case of TIO in a patient with metastatic breast cancer complicated by increased parathyroid hormone release secondary to denosumab-induced hypocalcemia. The patient required intensive intravenous and oral phosphate supplementation in addition to vitamin D repletion. A high index of clinical suspicion can yield the correct diagnosis where TIO arises in the setting of a solid organ tumor and help the clinician appropriately manage these challenging cases.
PMID: 33141014 [PubMed - as supplied by publisher]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Bhasin B, Velez JCQ Tags: Clin Nephrol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormones | Oral Cancer | Paraneoplastic Syndrome | Phosphorus | Vitamin D | Vitamins | Xgeva